Cargando…

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

BACKGROUND: Azithromycin, an antibiotic with potential antiviral and anti-inflammatory properties, has been used to treat COVID-19, but evidence from community randomised trials is lacking. We aimed to assess the effectiveness of azithromycin to treat suspected COVID-19 among people in the community...

Descripción completa

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972318/ https://www.ncbi.nlm.nih.gov/pubmed/33676597 http://dx.doi.org/10.1016/S0140-6736(21)00461-X

Ejemplares similares

Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
por: Butler, Christopher C, et al.
Publicado: (2021)

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
por: Yu, Ly-Mee, et al.
Publicado: (2021)

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Publicado: (2022)

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Publicado: (2021)

Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk
por: Hayward, Gail, et al.
Publicado: (2021)

Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial
por: Sekhavati, Ehsan, et al.
Publicado: (2020)

Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
por: Dorward, Jienchi, et al.
Publicado: (2022)

Azithromycin for sarcoidosis cough: an open-label exploratory clinical trial
por: Fraser, Simon D., et al.
Publicado: (2020)

Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO)
por: Gyselinck, Iwein, et al.
Publicado: (2022)

Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial
por: Hinks, Timothy S C, et al.
Publicado: (2021)

Hydroxychloroquine versus Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS). Protocol for a Pragmatic, Open-Label, Active Comparator Trial
por: Brown, Samuel M., et al.
Publicado: (2020)

Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease
por: Gbinigie, Oghenekome, et al.
Publicado: (2023)

Azithromycin and cefixime combination versus azithromycin alone for the out-patient treatment of clinically suspected or confirmed uncomplicated typhoid fever in South Asia: a randomised controlled trial protocol
por: Giri, Abhishek, et al.
Publicado: (2021)

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
por: Butler, Christopher C, et al.
Publicado: (2023)

Report of the first seven agents in the I-SPY COVID trial: a phase 2, open label, adaptive platform randomised controlled trial
Publicado: (2023)

Daily versus three-times-weekly azithromycin in Chinese patients with non-cystic fibrosis bronchiectasis: protocol for a prospective, open-label and randomised controlled trial
por: Mao, Yanxiong, et al.
Publicado: (2022)

Efficacy of Combination Therapy with Oseltamivir Phosphate and Azithromycin for Influenza: A Multicenter, Open-Label, Randomized Study
por: Kakeya, Hiroshi, et al.
Publicado: (2014)

A Prospective, Open-label, Randomized Trial of Doxycycline Versus Azithromycin for the Treatment of Uncomplicated Murine Typhus
por: Newton, Paul N, et al.
Publicado: (2019)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
por: Gautret, Philippe, et al.
Publicado: (2020)

Randomised controlled trial of azithromycin in smokers with asthma
por: Cameron, Euan J., et al.
Publicado: (2013)

A survival model for course-course interactions in a Massive Open Online Course platform
por: Wintermute, Edwin H., et al.
Publicado: (2021)

Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial
por: Gyselinck, Iwein, et al.
Publicado: (2021)

The Short versus Long Antibiotic Course for Pleural Infection Management (SLIM) randomised controlled open-label trial
por: Hassan, Maged, et al.
Publicado: (2023)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited
por: Gautret, Philippe, et al.
Publicado: (2021)

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Publicado: (2021)

Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Publicado: (2021)

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Publicado: (2022)

Cumulative life course adversity, mental health, and cognition in the UK biobank
por: Künzi, M., et al.
Publicado: (2022)

Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial
por: Gyselinck, Iwein, et al.
Publicado: (2021)

Randomised trial of azithromycin to eradicate Ureaplasma in preterm infants
por: Viscardi, Rose Marie, et al.
Publicado: (2020)

Azithromycin: Lack of efficacy and off-label use: case report
Publicado: (2021)

Referring to the study: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial
por: dos Santos, Marcelo Rodrigues
Publicado: (2021)

Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Publicado: (2020)

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Publicado: (2022)

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Publicado: (2021)

A multi-centre open-label two-arm randomised superiority clinical trial of azithromycin versus usual care in ambulatory COVID-19: study protocol for the ATOMIC2 trial
por: Hinks, Timothy S. C., et al.
Publicado: (2020)

Efficacy of azithromycin in severe asthma from the AMAZES randomised trial
por: Gibson, Peter G., et al.
Publicado: (2019)

Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)
por: Jittamala, Podjanee, et al.
Publicado: (2023)

Letter to the editor about “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial”
por: Saad, Mohamed O
Publicado: (2021)

Focus on clinical outcomes of “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial”
por: Wambier, Carlos Gustavo
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e1dk15geivigvb2i25d9h39agr